Cost-effectiveness of stereotactic body radiotherapy versus conventional radiotherapy for the treatment of surgically ineligible stage I non-small cell lung cancer in the Brazilian public health system

BACKGROUND: The Brazilian public health system does not pay for the use of Stereotactic body radiotherapy (SBRT) due to its costs and the absence of cost-effectiveness analysis showing its benefit. The present study aims to evaluate whether the SBRT is a more cost-effective strategy than the convent...

Descripción completa

Detalles Bibliográficos
Autores principales: Arruda, Gustavo Viani, Lourenção, Marina, de Oliveira, Jorge Henrique Caldeira, Galendi, Julia Simões Correa, Jacinto, Alexandre Arthur
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9903892/
https://www.ncbi.nlm.nih.gov/pubmed/36777381
http://dx.doi.org/10.1016/j.lana.2022.100329

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9903892/
https://www.ncbi.nlm.nih.gov/pubmed/36777381
http://dx.doi.org/10.1016/j.lana.2022.100329

Ejemplares similares